Page last updated: 2024-11-13

bi 653048 bs h3po4

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

BI 653048 BS H3PO4: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID44543970
CHEMBL ID3358954
SCHEMBL ID1493900
MeSH IDM0586818

Synonyms (22)

Synonym
chembl3358954 ,
bdbm50041896
SCHEMBL1493900
bi 653048 bs h3po4
gtpl9715
(r)-2-(4-((5-(ethylsulfonyl)-1h-pyrrolo[2,3-c]pyridin-2-yl)methyl)-5,5,5-trifluoro-4-hydroxy-2-methylpentan-2-yl)-5-fluorobenzamide
bi-653048
bi653048
(r)-39
bi 653048
HY-12946
CS-0012809
kq33evh4ku ,
2-((3r)-3-((5-(ethylsulfonyl)-1h-pyrrolo(2,3-c)pyridin-2-yl)methyl)-4,4,4-trifluoro-3-hydroxy-1,1-dimethylbutyl)-5-fluorobenzamide
2-((4r)-4-((5-ethylsulfonyl-1h-pyrrolo(2,3-c)pyridin-2-yl)methyl)-5,5,5-trifluoro-4-hydroxy-2-methylpentan-2-yl)-5-fluorobenzamide
benzamide, 2-((3r)-3-((5-(ethylsulfonyl)-1h-pyrrolo(2,3-c)pyridin-2-yl)methyl)-4,4,4-trifluoro-3-hydroxy-1,1-dimethylbutyl)-5-fluoro-
bi-653048 free base
unii-kq33evh4ku
2-[(4r)-4-[(5-ethylsulfonyl-1h-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5,5,5-trifluoro-4-hydroxy-2-methylpentan-2-yl]-5-fluorobenzamide
1198784-72-3
auifrjwxyunppv-qfipxvfzsa-n
AKOS040732594

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" This led to the discovery of AZD9567 (15) with excellent in vivo efficacy when dosed orally in a rat model of joint inflammation."( Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.
Berger, M; Bird, J; Chang, HF; Chapman, D; Dearman, M; Drmota, T; Edenro, G; Edman, K; Geschwindner, S; Harrison, R; Hegelund-Myrbäck, T; Hendrickx, R; Köhler, C; Lawitz, K; Lepistö, M; Llinas, A; Malmberg, J; Nikitidis, A; Olsson, RI; Ripa, L; Svanberg, P; Thorne, P; Ullah, V; Wissler, L, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (9)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glucocorticoid receptorHomo sapiens (human)IC50 (µMol)0.28920.00000.495310.0000AID1176698; AID1176700; AID1380129; AID1380136; AID1380145; AID1790400; AID1912857; AID1913359
Cytochrome P450 1A2Homo sapiens (human)IC50 (µMol)50.00000.00011.774010.0000AID1176709
Interleukin-6Homo sapiens (human)IC50 (µMol)0.02300.02300.11550.2080AID1790401
Glucocorticoid receptorMus musculus (house mouse)IC50 (µMol)0.60000.00220.20610.6000AID1176715
Cytochrome P450 3A4Homo sapiens (human)IC50 (µMol)8.00000.00011.753610.0000AID1176702
Cytochrome P450 2D6Homo sapiens (human)IC50 (µMol)41.00000.00002.015110.0000AID1176710
Cytochrome P450 2C9 Homo sapiens (human)IC50 (µMol)12.00000.00002.800510.0000AID1176711
Cytochrome P450 2C19Homo sapiens (human)IC50 (µMol)9.00000.00002.398310.0000AID1176712
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)IC50 (µMol)30.00000.00091.901410.0000AID1176704
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glucocorticoid receptorHomo sapiens (human)fIC200.00120.00090.00100.0012AID1380148
Glucocorticoid receptorHomo sapiens (human)fIC300.08100.02000.05050.0810AID1380145
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (182)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IIGlucocorticoid receptorHomo sapiens (human)
regulation of gluconeogenesisGlucocorticoid receptorHomo sapiens (human)
chromatin organizationGlucocorticoid receptorHomo sapiens (human)
regulation of DNA-templated transcriptionGlucocorticoid receptorHomo sapiens (human)
apoptotic processGlucocorticoid receptorHomo sapiens (human)
chromosome segregationGlucocorticoid receptorHomo sapiens (human)
signal transductionGlucocorticoid receptorHomo sapiens (human)
glucocorticoid metabolic processGlucocorticoid receptorHomo sapiens (human)
gene expressionGlucocorticoid receptorHomo sapiens (human)
microglia differentiationGlucocorticoid receptorHomo sapiens (human)
adrenal gland developmentGlucocorticoid receptorHomo sapiens (human)
regulation of glucocorticoid biosynthetic processGlucocorticoid receptorHomo sapiens (human)
synaptic transmission, glutamatergicGlucocorticoid receptorHomo sapiens (human)
maternal behaviorGlucocorticoid receptorHomo sapiens (human)
intracellular glucocorticoid receptor signaling pathwayGlucocorticoid receptorHomo sapiens (human)
glucocorticoid mediated signaling pathwayGlucocorticoid receptorHomo sapiens (human)
positive regulation of neuron apoptotic processGlucocorticoid receptorHomo sapiens (human)
negative regulation of DNA-templated transcriptionGlucocorticoid receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIGlucocorticoid receptorHomo sapiens (human)
astrocyte differentiationGlucocorticoid receptorHomo sapiens (human)
cell divisionGlucocorticoid receptorHomo sapiens (human)
mammary gland duct morphogenesisGlucocorticoid receptorHomo sapiens (human)
motor behaviorGlucocorticoid receptorHomo sapiens (human)
cellular response to steroid hormone stimulusGlucocorticoid receptorHomo sapiens (human)
cellular response to glucocorticoid stimulusGlucocorticoid receptorHomo sapiens (human)
cellular response to dexamethasone stimulusGlucocorticoid receptorHomo sapiens (human)
cellular response to transforming growth factor beta stimulusGlucocorticoid receptorHomo sapiens (human)
neuroinflammatory responseGlucocorticoid receptorHomo sapiens (human)
positive regulation of miRNA transcriptionGlucocorticoid receptorHomo sapiens (human)
intracellular steroid hormone receptor signaling pathwayGlucocorticoid receptorHomo sapiens (human)
regulation of transcription by RNA polymerase IIGlucocorticoid receptorHomo sapiens (human)
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activityInterleukin-6Homo sapiens (human)
positive regulation of platelet aggregationInterleukin-6Homo sapiens (human)
positive regulation of receptor signaling pathway via STATInterleukin-6Homo sapiens (human)
negative regulation of primary miRNA processingInterleukin-6Homo sapiens (human)
positive regulation of gene expressionInterleukin-6Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationInterleukin-6Homo sapiens (human)
maintenance of blood-brain barrierInterleukin-6Homo sapiens (human)
positive regulation of MAPK cascadeInterleukin-6Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterleukin-6Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationInterleukin-6Homo sapiens (human)
cellular response to lipopolysaccharideInterleukin-6Homo sapiens (human)
positive regulation of leukocyte adhesion to vascular endothelial cellInterleukin-6Homo sapiens (human)
neutrophil apoptotic processInterleukin-6Homo sapiens (human)
germinal center B cell differentiationInterleukin-6Homo sapiens (human)
hepatic immune responseInterleukin-6Homo sapiens (human)
neutrophil mediated immunityInterleukin-6Homo sapiens (human)
monocyte chemotaxisInterleukin-6Homo sapiens (human)
positive regulation of immunoglobulin productionInterleukin-6Homo sapiens (human)
positive regulation of acute inflammatory responseInterleukin-6Homo sapiens (human)
positive regulation of leukocyte chemotaxisInterleukin-6Homo sapiens (human)
acute-phase responseInterleukin-6Homo sapiens (human)
inflammatory responseInterleukin-6Homo sapiens (human)
humoral immune responseInterleukin-6Homo sapiens (human)
positive regulation of cell population proliferationInterleukin-6Homo sapiens (human)
negative regulation of cell population proliferationInterleukin-6Homo sapiens (human)
vascular endothelial growth factor productionInterleukin-6Homo sapiens (human)
regulation of vascular endothelial growth factor productionInterleukin-6Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionInterleukin-6Homo sapiens (human)
positive regulation of gene expressionInterleukin-6Homo sapiens (human)
positive regulation of epithelial to mesenchymal transitionInterleukin-6Homo sapiens (human)
negative regulation of lipid storageInterleukin-6Homo sapiens (human)
response to activityInterleukin-6Homo sapiens (human)
cytokine-mediated signaling pathwayInterleukin-6Homo sapiens (human)
platelet activationInterleukin-6Homo sapiens (human)
endocrine pancreas developmentInterleukin-6Homo sapiens (human)
neuron projection developmentInterleukin-6Homo sapiens (human)
response to peptidoglycanInterleukin-6Homo sapiens (human)
negative regulation of chemokine productionInterleukin-6Homo sapiens (human)
positive regulation of chemokine productionInterleukin-6Homo sapiens (human)
positive regulation of interleukin-1 beta productionInterleukin-6Homo sapiens (human)
positive regulation of interleukin-10 productionInterleukin-6Homo sapiens (human)
positive regulation of interleukin-17 productionInterleukin-6Homo sapiens (human)
positive regulation of interleukin-21 productionInterleukin-6Homo sapiens (human)
positive regulation of interleukin-6 productionInterleukin-6Homo sapiens (human)
positive regulation of interleukin-8 productionInterleukin-6Homo sapiens (human)
positive regulation of tumor necrosis factor productionInterleukin-6Homo sapiens (human)
negative regulation of collagen biosynthetic processInterleukin-6Homo sapiens (human)
positive regulation of T cell proliferationInterleukin-6Homo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT proteinInterleukin-6Homo sapiens (human)
glucose homeostasisInterleukin-6Homo sapiens (human)
positive regulation of apoptotic processInterleukin-6Homo sapiens (human)
negative regulation of apoptotic processInterleukin-6Homo sapiens (human)
positive regulation of MAPK cascadeInterleukin-6Homo sapiens (human)
negative regulation of fat cell differentiationInterleukin-6Homo sapiens (human)
positive regulation of osteoblast differentiationInterleukin-6Homo sapiens (human)
positive regulation of translationInterleukin-6Homo sapiens (human)
regulation of angiogenesisInterleukin-6Homo sapiens (human)
negative regulation of bone resorptionInterleukin-6Homo sapiens (human)
positive regulation of DNA-templated transcriptionInterleukin-6Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterleukin-6Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATInterleukin-6Homo sapiens (human)
positive regulation of smooth muscle cell proliferationInterleukin-6Homo sapiens (human)
negative regulation of neurogenesisInterleukin-6Homo sapiens (human)
regulation of insulin secretionInterleukin-6Homo sapiens (human)
defense response to Gram-negative bacteriumInterleukin-6Homo sapiens (human)
defense response to Gram-positive bacteriumInterleukin-6Homo sapiens (human)
positive regulation of B cell activationInterleukin-6Homo sapiens (human)
positive regulation of DNA-binding transcription factor activityInterleukin-6Homo sapiens (human)
response to glucocorticoidInterleukin-6Homo sapiens (human)
defense response to virusInterleukin-6Homo sapiens (human)
positive regulation of glial cell proliferationInterleukin-6Homo sapiens (human)
T follicular helper cell differentiationInterleukin-6Homo sapiens (human)
regulation of astrocyte activationInterleukin-6Homo sapiens (human)
neuron cellular homeostasisInterleukin-6Homo sapiens (human)
glucagon secretionInterleukin-6Homo sapiens (human)
regulation of glucagon secretionInterleukin-6Homo sapiens (human)
interleukin-6-mediated signaling pathwayInterleukin-6Homo sapiens (human)
cellular response to hydrogen peroxideInterleukin-6Homo sapiens (human)
T-helper 17 cell lineage commitmentInterleukin-6Homo sapiens (human)
hepatocyte proliferationInterleukin-6Homo sapiens (human)
positive regulation of extracellular matrix disassemblyInterleukin-6Homo sapiens (human)
inflammatory response to woundingInterleukin-6Homo sapiens (human)
liver regenerationInterleukin-6Homo sapiens (human)
cellular response to virusInterleukin-6Homo sapiens (human)
regulation of neuroinflammatory responseInterleukin-6Homo sapiens (human)
positive regulation of neuroinflammatory responseInterleukin-6Homo sapiens (human)
positive regulation of cytokine production involved in inflammatory responseInterleukin-6Homo sapiens (human)
positive regulation of apoptotic DNA fragmentationInterleukin-6Homo sapiens (human)
regulation of microglial cell activationInterleukin-6Homo sapiens (human)
positive regulation of T-helper 2 cell cytokine productionInterleukin-6Homo sapiens (human)
negative regulation of interleukin-1-mediated signaling pathwayInterleukin-6Homo sapiens (human)
positive regulation of type B pancreatic cell apoptotic processInterleukin-6Homo sapiens (human)
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2D6Homo sapiens (human)
steroid metabolic processCytochrome P450 2D6Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2D6Homo sapiens (human)
estrogen metabolic processCytochrome P450 2D6Homo sapiens (human)
coumarin metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid catabolic processCytochrome P450 2D6Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2D6Homo sapiens (human)
isoquinoline alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2D6Homo sapiens (human)
retinol metabolic processCytochrome P450 2D6Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2D6Homo sapiens (human)
negative regulation of bindingCytochrome P450 2D6Homo sapiens (human)
oxidative demethylationCytochrome P450 2D6Homo sapiens (human)
negative regulation of cellular organofluorine metabolic processCytochrome P450 2D6Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 2D6Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C9 Homo sapiens (human)
steroid metabolic processCytochrome P450 2C9 Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2C9 Homo sapiens (human)
estrogen metabolic processCytochrome P450 2C9 Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C9 Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
urea metabolic processCytochrome P450 2C9 Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 2C9 Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C9 Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
amide metabolic processCytochrome P450 2C9 Homo sapiens (human)
icosanoid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
oxidative demethylationCytochrome P450 2C9 Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 2C19Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C19Homo sapiens (human)
steroid metabolic processCytochrome P450 2C19Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C19Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C19Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C19Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C19Homo sapiens (human)
regulation of heart rate by cardiac conductionPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
regulation of heart rate by hormonePotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
regulation of membrane potentialPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
positive regulation of DNA-templated transcriptionPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
potassium ion homeostasisPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
cardiac muscle contractionPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
regulation of membrane repolarizationPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
regulation of ventricular cardiac muscle cell membrane repolarizationPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
cellular response to xenobiotic stimulusPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
potassium ion transmembrane transportPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
ventricular cardiac muscle cell action potentialPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
membrane repolarizationPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
membrane depolarization during action potentialPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
membrane repolarization during action potentialPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
membrane repolarization during cardiac muscle cell action potentialPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
regulation of heart rate by cardiac conductionPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
potassium ion export across plasma membranePotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
membrane repolarization during ventricular cardiac muscle cell action potentialPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
regulation of potassium ion transmembrane transportPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
negative regulation of potassium ion transmembrane transportPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
positive regulation of potassium ion transmembrane transportPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
negative regulation of potassium ion export across plasma membranePotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
potassium ion import across plasma membranePotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (65)

Processvia Protein(s)Taxonomy
RNA polymerase II transcription regulatory region sequence-specific DNA bindingGlucocorticoid receptorHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingGlucocorticoid receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificGlucocorticoid receptorHomo sapiens (human)
core promoter sequence-specific DNA bindingGlucocorticoid receptorHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificGlucocorticoid receptorHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificGlucocorticoid receptorHomo sapiens (human)
DNA-binding transcription factor activityGlucocorticoid receptorHomo sapiens (human)
RNA bindingGlucocorticoid receptorHomo sapiens (human)
nuclear receptor activityGlucocorticoid receptorHomo sapiens (human)
nuclear glucocorticoid receptor activityGlucocorticoid receptorHomo sapiens (human)
steroid bindingGlucocorticoid receptorHomo sapiens (human)
protein bindingGlucocorticoid receptorHomo sapiens (human)
zinc ion bindingGlucocorticoid receptorHomo sapiens (human)
TBP-class protein bindingGlucocorticoid receptorHomo sapiens (human)
protein kinase bindingGlucocorticoid receptorHomo sapiens (human)
identical protein bindingGlucocorticoid receptorHomo sapiens (human)
Hsp90 protein bindingGlucocorticoid receptorHomo sapiens (human)
steroid hormone bindingGlucocorticoid receptorHomo sapiens (human)
sequence-specific double-stranded DNA bindingGlucocorticoid receptorHomo sapiens (human)
estrogen response element bindingGlucocorticoid receptorHomo sapiens (human)
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
interleukin-6 receptor bindingInterleukin-6Homo sapiens (human)
cytokine activityInterleukin-6Homo sapiens (human)
interleukin-6 receptor bindingInterleukin-6Homo sapiens (human)
protein bindingInterleukin-6Homo sapiens (human)
growth factor activityInterleukin-6Homo sapiens (human)
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
monooxygenase activityCytochrome P450 2D6Homo sapiens (human)
iron ion bindingCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activityCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2D6Homo sapiens (human)
heme bindingCytochrome P450 2D6Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
iron ion bindingCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 14,15-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 11,12-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
caffeine oxidase activityCytochrome P450 2C9 Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
aromatase activityCytochrome P450 2C9 Homo sapiens (human)
heme bindingCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C9 Homo sapiens (human)
monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
iron ion bindingCytochrome P450 2C19Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C19Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C19Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
oxygen bindingCytochrome P450 2C19Homo sapiens (human)
enzyme bindingCytochrome P450 2C19Homo sapiens (human)
heme bindingCytochrome P450 2C19Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
aromatase activityCytochrome P450 2C19Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 2C19Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C19Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C19Homo sapiens (human)
transcription cis-regulatory region bindingPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
inward rectifier potassium channel activityPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
voltage-gated potassium channel activityPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
delayed rectifier potassium channel activityPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
protein bindingPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
ubiquitin protein ligase bindingPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
identical protein bindingPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
protein homodimerization activityPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
C3HC4-type RING finger domain bindingPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarizationPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
scaffold protein bindingPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarizationPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (25)

Processvia Protein(s)Taxonomy
nucleusGlucocorticoid receptorHomo sapiens (human)
nucleusGlucocorticoid receptorHomo sapiens (human)
nucleoplasmGlucocorticoid receptorHomo sapiens (human)
cytoplasmGlucocorticoid receptorHomo sapiens (human)
mitochondrial matrixGlucocorticoid receptorHomo sapiens (human)
centrosomeGlucocorticoid receptorHomo sapiens (human)
spindleGlucocorticoid receptorHomo sapiens (human)
cytosolGlucocorticoid receptorHomo sapiens (human)
membraneGlucocorticoid receptorHomo sapiens (human)
nuclear speckGlucocorticoid receptorHomo sapiens (human)
synapseGlucocorticoid receptorHomo sapiens (human)
chromatinGlucocorticoid receptorHomo sapiens (human)
protein-containing complexGlucocorticoid receptorHomo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
extracellular spaceInterleukin-6Homo sapiens (human)
extracellular regionInterleukin-6Homo sapiens (human)
extracellular spaceInterleukin-6Homo sapiens (human)
endoplasmic reticulum lumenInterleukin-6Homo sapiens (human)
interleukin-6 receptor complexInterleukin-6Homo sapiens (human)
nucleoplasmGlucocorticoid receptorMus musculus (house mouse)
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
mitochondrionCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulumCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2D6Homo sapiens (human)
cytoplasmCytochrome P450 2D6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C9 Homo sapiens (human)
plasma membraneCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
cytoplasmCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C19Homo sapiens (human)
plasma membraneCytochrome P450 2C19Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C19Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C19Homo sapiens (human)
cytoplasmCytochrome P450 2C19Homo sapiens (human)
plasma membranePotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
cell surfacePotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
perinuclear region of cytoplasmPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
voltage-gated potassium channel complexPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
inward rectifier potassium channel complexPotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
plasma membranePotassium voltage-gated channel subfamily H member 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (38)

Assay IDTitleYearJournalArticle
AID1176716Antiarthritic effect in 9-day type-2 collagen-induced rat arthritis model assessed as reduction in ankle inflammation at 3 mg/kg, po qd2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176700Agonist activity at GR in HFF cells assessed as suppression of IL-1-induced IL-6 production2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1380136Transrepression activity at glucocorticoid receptor (unknown origin) expressed in human ChaGoK1 cells assessed as inhibition of PMA-stimulated gene expression incubated for 24 hrs by beta-galactosidase reporter gene assay2018Journal of medicinal chemistry, 03-08, Volume: 61, Issue:5
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.
AID1380131Transactivation activity at glucocorticoid receptor (unknown origin) expressed in human ChaGoK1 cells at 1 uM incubated for 24 hrs by beta-galactosidase reporter gene assay2018Journal of medicinal chemistry, 03-08, Volume: 61, Issue:5
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.
AID1176721Antiarthritic effect in 9-day type-2 collagen-induced rat arthritis model assessed as reduction in bone resorption at 10 mg/kg, po qd2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1380145Transrepression of GR in human whole blood assessed as inhibition of LPS-induced TNF-alpha release preincubated for 45 mins followed by LPS addition after 18 hrs by AlphaLISA method2018Journal of medicinal chemistry, 03-08, Volume: 61, Issue:5
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.
AID1176717Antiarthritic effect in 9-day type-2 collagen-induced rat arthritis model assessed as reduction in pannus formation at 3 mg/kg, po qd2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176708Agonist activity at GR in human MG-63 cells assessed as inhibition of vitamin D-induced osteocalcin production at 2 uM relative to dexamethasone2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176707Agonist activity at GR in human HeLa cells transfected with MMTV promoter at 2 uM by luciferase transactivation assay relative to dexamethasone2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176722Antiarthritic effect in 9-day type-2 collagen-induced rat arthritis model assessed as reduction in ankle inflammation at 30 mg/kg, po qd2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176719Antiarthritic effect in 9-day type-2 collagen-induced rat arthritis model assessed as reduction in bone resorption at 3 mg/kg, po qd2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1380139Aqueous solubility of the compound2018Journal of medicinal chemistry, 03-08, Volume: 61, Issue:5
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.
AID1176705Thermodynamic solubility of the compound in buffer at pH 6.8 after 24 hrs by HPLC analysis2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1380129Displacement of fluormone RED from human full length glucocorticoid receptor after 4 hrs by fluorescence polarization assay2018Journal of medicinal chemistry, 03-08, Volume: 61, Issue:5
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.
AID1380147Therapeutic index, ratio of fEC50 for transactivation of GR in cryopreserved human primary hepatocytes assessed as upregulation of TAT mRNA expression level to fIC30 for transrepression of GR in human whole blood assessed as inhibition of LPS-induced TNF-2018Journal of medicinal chemistry, 03-08, Volume: 61, Issue:5
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.
AID1176723Antiarthritic effect in 9-day type-2 collagen-induced rat arthritis model assessed as reduction in pannus formation at 30 mg/kg, po qd2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176720Antiarthritic effect in 9-day type-2 collagen-induced rat arthritis model assessed as reduction in pannus formation at 10 mg/kg, po qd2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176718Antiarthritic effect in 9-day type-2 collagen-induced rat arthritis model assessed as reduction in cartilage damage at 3 mg/kg, po qd2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176710Inhibition of CYP2D6 (unknown origin)2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176711Inhibition of CYP2C9 (unknown origin)2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1380138Transrepression activity at glucocorticoid receptor (unknown origin) expressed in human ChaGoK1 cells assessed as inhibition of PMA-stimulated gene expression incubated for 24 hrs by beta-galactosidase reporter gene assay relative to dexamethasone2018Journal of medicinal chemistry, 03-08, Volume: 61, Issue:5
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.
AID1176714Clearance in human liver microsomes after 60 mins by HPLC analysis relative to hepatic blood flow2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176724Antiarthritic effect in 9-day type-2 collagen-induced rat arthritis model assessed as reduction in cartilage damage at 30 mg/kg, po qd2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1380128Transactivation of GR in cryopreserved human primary hepatocytes assessed as upregulation of TAT mRNA expression level after 18 hrs by RT-qPCR analysis2018Journal of medicinal chemistry, 03-08, Volume: 61, Issue:5
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.
AID1176696Antiarthritic effect in po dosed 9-day type-2 collagen-induced rat arthritis model administered qd2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176715Agonist activity at GR in mouse RAW cells assessed as suppression of TNF-alpha-induced IL-6 production2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176704Inhibition of human ERG channel expressed in recombinant HEK293 cells by whole cell patch-clamp technique2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176697Toxicity in po dosed 9-day type-2 collagen-induced rat arthritis model administered qd2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176709Inhibition of CYP1A2 (unknown origin)2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1380148Transrepression of GR in cryopreserved human fetal osteoblasts assessed as inhibition of OPG mRNA expression after 4 hrs by RT-qPCR analysis2018Journal of medicinal chemistry, 03-08, Volume: 61, Issue:5
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.
AID1176695Antiarthritic effect in 9-day type-2 collagen-induced rat arthritis model assessed as reduction in bone resorption at 30 mg/kg, po qd2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1380149Therapeutic index, ratio of fIC20 for transrepression of GR in cryopreserved human fetal osteoblasts assessed as inhibition of OPG mRNA expression to fIC30 for transrepression of GR in human whole blood assessed as inhibition of LPS-induced TNF-alpha rele2018Journal of medicinal chemistry, 03-08, Volume: 61, Issue:5
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.
AID1176698Displacement of RU-486 from GR (unknown origin) by fluorescence polarization assay2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176713Half life in rat2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176702Inhibition of human recombinant CYP3A4 using 7-benzyloxy-4-(trifluoromethyl)-coumarin as substrate after 30 mins by fluorescence assay2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176701Agonist activity at GR in HFF cells assessed as suppression of IL-1-induced IL-6 production at 2 uM relative to dexamethasone2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1176712Inhibition of CYP2C19 (unknown origin)2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
AID1346849Human Glucocorticoid receptor (3C. 3-Ketosteroid receptors)2014ACS medicinal chemistry letters, Dec-11, Volume: 5, Issue:12
Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.56 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]